Pepdexpepdex
Stack
โ„– 028

HGH Fragment 176-191

The fat-loss tail of the HGH molecule, isolated and used alone. Goal: trigger lipolysis without GH's water retention or insulin impact.

Fat Loss
Evidence: Limited

HGH Fragment 176-191: The fat-loss tail of the HGH molecule, isolated and used alone. Goal: trigger lipolysis without GH's water retention or insulin impact. HGH Fragment 176-191 is the part of the HGH molecule that handles fat metabolism, isolated and used alone.

FDA โ“˜
Not approved
WADA
Banned
Typical dose
250-500 mcg sub-q
Half-life โ“˜
~30 minutes
Route โ“˜
Subcutaneous
Schedule
1-2x daily, fasted
In plain English

HGH Fragment 176-191 is the part of the HGH molecule that handles fat metabolism, isolated and used alone. The point: get the fat-loss signal without GH's water retention or insulin resistance. Daily injection, fasted.

Status & legalityWhat do these mean? โ†’
Natty? โ“˜
Not natty
FDA โ“˜
Not approved

Not FDA approved. Failed obesity development.

Compounding โ“˜
Not classified

Not formally categorized in the FDA bulks lists.

WADA โ“˜
Banned (S2)

As a fragment of HGH, falls under the S2 peptide hormones category.

Prescribed โ“˜

Not prescribed in conventional medicine.

Who it's for

  • โ†’Users wanting GH-style fat-loss signal without the bulky side effects
  • โ†’Cuts where GH-axis stacks would be too aggressive

What to expect

  1. Week 1

    Subtle. Fasted-cardio tolerance often improves first.

  2. Week 4

    Body comp shifts in users running it alongside a clean diet.

  3. Week 8

    Plateau. Cycle off.

Looking at HGH Fragment 176-191? Your next 3 steps

  1. 1Work out your syringe units

    Vial size + BAC water turns into the exact units to draw for HGH Fragment 176-191.

    Open calculator โ†’
  2. 2See what to stack & monitor

    The companion supplements and the bloodwork worth tracking on this kind of protocol.

    Bloodwork guide โ†’
  3. 3Save it & ask the Coach

    A free account gets you Coach questions every day, free; membership saves your stack and makes the Coach stack-aware.

    Create free account โ†’

How it works (mechanism)

Same as AOD-9604 mechanistically, the HGH fragment isolated to retain lipolysis without IGF-1 stimulation. Sometimes used interchangeably with AOD-9604.

Dosing protocol

Members only

Stacks well with

Members only

Side effects

01Mild injection-site irritation
02Rare: headache

When NOT to use

  • โš Active malignancy
  • โš Pregnancy / nursing

Common mistakes

  • โ€ข Expecting GLP-class results (it isn't that potent)
  • โ€ข Dosing post-meal (blunts the lipolytic effect)
  • โ€ข Running short cycles and quitting before adaptation

What it actually is

HGH Fragment 176-191 is the tail section of the human growth hormone molecule, residues 176 to 191, sold on its own. It is the unmodified version of the same idea behind AOD-9604, which added a stabilising change and then failed its clinical trials. Its literature is also harder to pin down than it looks: our exact search term returns one record, but related work exists under hGH(177-191), AOD9401 and Tyr-substituted variants, and grey-market product sold under this name is used ambiguously for the native and modified sequences. So one paper describes our query, not the field.

The proposal is that this fragment retains growth hormone's fat-mobilising action while leaving behind the parts of the molecule that raise IGF-1, retain water and affect insulin sensitivity. The preclinical picture is mixed and mostly comes from adjacent or modified fragments rather than this exact sequence: an early hGH(177-191) study found antilipogenic activity but no significant lipolytic effect, while later AOD9401 and AOD-9604 work reported lipolysis. Whether an injected fragment survives long enough, reaches fat tissue in sufficient quantity, and produces measurable fat loss in a person is the part that has never been demonstrated.

Forms, and which is which

Lyophilised powder, subcutaneousHow all use happens

Buyer reconstitutes. Research-chemical supply, unverified identity, and with a compound this obscure there is little to compare a vial against.

Verdict: The only real form, entirely unverified.

AOD-9604The tested version of the same idea

The stabilised analog that actually reached human trials, and did not beat placebo.

Verdict: The same concept with an actual negative result attached.

Oral or sublingualNothing

Not absorbed intact as an active dose by these routes.

Verdict: Not plausible as described.

Blends with other fat-loss peptidesMarketing

Combines compounds without human evidence, making any result unattributable.

Verdict: Several unknowns at once.

What it is claimed to do, graded

Causes fat loss in humansNone shown

No human trial. The closely related AOD-9604 was tested for this and failed, which is the most informative thing available about this fragment.

Stimulates lipolysis in fat cellsLimited

Mixed preclinical results, largely from adjacent or modified fragments rather than this exact sequence.

Avoids growth hormone's side effectsLimited

Mechanistically plausible and largely untested in people, and only relevant if it did something worth having.

Is safeNone shown

One indexed paper exists for this compound in total. There is no safety literature to draw on.

Grades describe how much human evidence exists for that specific claim, not whether it will work for you or whether it is safe.

Pros and cons

Pros
  • โ€ข Cheap
  • โ€ข The underlying idea โ€” separating growth hormone's fat action from the rest โ€” is a real one that was taken seriously enough to fund trials of its stabilised cousin
Cons
  • โ€ข One indexed paper, and it is not about fat loss โ€” grade F on the site's own ladder
  • โ€ข The closest relative with real trials failed them
  • โ€ข No human safety, pharmacokinetic, glucose or IGF-1 data for this exact sequence. Older related-fragment animal work does include glucose effects, so the frequently repeated 'does not affect blood sugar' is not established either
  • โ€ข Research-chemical supply with unverified identity
  • โ€ข Frequently sold as if AOD-9604's trial history were its own

When to stop

  • โ€ข Eight to twelve weeks with no change against a controlled diet
  • โ€ข Injection-site reaction that spreads
  • โ€ข Any new cancer diagnosis

Interactions

Active malignancyAvoid

A growth hormone fragment in a body with a tumour is unstudied.

Other fat-loss compoundsCaution

Stacking makes any result unattributable.

A calorie deficitCompatible

The intervention that actually produces the result.

Growth hormoneMonitor

No interaction data. Same parent molecule.

Nothing well characterisedCaution

There is no human interaction literature for this compound at all.

Is this for you?

Probably worth reading further if
  • โ€ข Realistically nobody โ€” the version of this idea that was actually tested did not work
Skip it if
  • โ€ข You want fat loss with any evidence behind it
  • โ€ข You have active cancer
  • โ€ข You are pregnant or nursing
  • โ€ข You are being sold AOD-9604's trial history as if it belonged to this

The one number

One record returned for the exact search term, and it is a drug-delivery study rather than a fat-loss one
Pepdex evidence index โ€” this counts records matching one query string, not the literature across every alias of this fragment

Sources for the claims above

Community patterns

Members only
Free, no account needed

New to HGH Fragment 176-191? Grab the starter checklist.

Drop your email and we'll send the one-page starter checklist beginners actually need first. No account needed.

No spam, and we never sell your email. Just the checklist. Email support@pepdex.co to opt out any time.

AI Coach, live sample
Member answer
is 250mcg of bpc enough for a knee injury?
For a knee, is the standard working dose and a solid place to start. The trick with BPC is consistency, give it weeks, not days. , run it , and don't drop below , results tend to fall off under that line. If nothing's moved by week 3, that's when earns its place.
how much bac water for a 10mg reta vial?
is the standard play for a 10 mg reta vial. That gives you , clean unit math across the whole titration: on a 100-unit insulin syringe. Run instead if you want fewer, more concentrated shots. Most people titrate up over , and that mix keeps the numbers cleanest.
what should i track on bloodwork for tirzepatide?
Lipid panel, ALT/AST (liver enzymes), and an A1C, baseline before you start then every 3 months. If you've got metabolic-syndrome history, add fasting glucose and insulin so you can actually watch insulin sensitivity improve. You don't need a big hormone panel for a GLP-1.

Numbers redacted in this preview. Members get the full answer, on their own stack.

Ask the Coach anything about HGH Fragment 176-191 or your own stack. This is it working.

Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.

Unlock the full Coach, from $4.99/week โ†’

Frequently asked

What is HGH Fragment 176-191?+
HGH Fragment 176-191 is the part of the HGH molecule that handles fat metabolism, isolated and used alone. The point: get the fat-loss signal without GH's water retention or insulin resistance. Daily injection, fasted.
Is HGH Fragment 176-191 FDA approved?+
Not FDA approved. Failed obesity development.
Is HGH Fragment 176-191 legal?+
HGH Fragment 176-191 is not FDA-approved, so there is no approved prescription version. Most supply is sold as "research only" by peptide vendors. A compounding pharmacy may only use substances the FDA permits for compounding, and many research peptides are not permitted โ€” do not assume a compounded prescription is available. Possession is generally not criminalized but distribution without authorization may be. Verify local laws.
Is HGH Fragment 176-191 banned by WADA?+
HGH Fragment 176-191 is on the WADA prohibited list under Banned (S2). As a fragment of HGH, falls under the S2 peptide hormones category.
Are you still natty after taking HGH Fragment 176-191?+
No. HGH Fragment 176-191 is a performance-enhancing peptide and would disqualify a strict natty claim.
Do doctors prescribe HGH Fragment 176-191?+
Not prescribed in conventional medicine.
What's the typical dose of HGH Fragment 176-191?+
Dosing depends on your goal, experience, and tolerance. The full HGH Fragment 176-191 protocol (dose, frequency, and how to titrate) is in the members section on the entry page.
What are the side effects of HGH Fragment 176-191?+
Common side effects include: Mild injection-site irritation; Rare: headache. Less common effects and full safety details are on the entry page.
How long until HGH Fragment 176-191 starts working?+
Subtle. Fasted-cardio tolerance often improves first.
What can you stack with HGH Fragment 176-191?+
HGH Fragment 176-191 is commonly combined with complementary compounds. The full stacking protocol (what to pair, dosing, and timing) is in the members section on the entry page.
Where do people get HGH Fragment 176-191?+
Pepdex does not sell, ship, or recommend suppliers. HGH Fragment 176-191 is not FDA-approved; prescription versions require licensed clinical care, and "research only" markets carry real legal and quality risks. /coa explains how to verify a Certificate of Analysis and /guides/scam-vendor-spotting covers the red flags.
HGH Fragment 176-191 vs AOD-9604, which is better?+
AOD-9604 vs HGH Fragment 176-191: two HGH-derived fat-loss peptides. Mechanism overlap and practical differences. Full head-to-head comparison: https://pepdex.co/compare/aod-9604-vs-hgh-frag-176-191

Common questions about HGH Fragment 176-191

Head-to-head with HGH Fragment 176-191

Compare
HGH Fragment 176-191 vs AOD-9604 โ†’

Tracked alongside HGH Fragment 176-191

Same goal, different aisle โ€” each graded on its own evidence in the Pepdex catalog.

Whey protein โ†’
muscle preservation is the open question on any GLP-1 run
Electrolytes โ†’
appetite suppression cuts fluid and sodium intake with it
Fiber โ†’
the constipation answer that shows up in every GLP-1 thread
Metformin โ†’
the prescription neighbour people compare these protocols against

More in Fat Loss

โ„– 009
Tirzepatide

Strong weight loss with a cleaner side effect profile than semaglutide. A dual agonist (GLP-1 + GIP), FDA-approved as Mounjaro / Zepbound.

โ„– 010
Semaglutide

The original weight-loss wave, sold as Ozempic / Wegovy. A GLP-1 agonist.

โ„– 003
Retatrutide

Triple agonist (GLP-1 + GIP + glucagon) from Eli Lilly. In trials it outperforms Tirzepatide for weight loss.

โ„– 059
Liraglutide (Saxenda / Victoza)

Daily GLP-1 receptor agonist. FDA-approved 2010 (Victoza, T2D) and 2014 (Saxenda, obesity). The first wave of modern GLP-1 weight-loss therapy and direct predecessor to Semaglutide.